Rationing in urologic oncology: Lessons from sipuleucel-T for advanced prostate cancer

Advanced prostate cancer – lessons from

Advanced prostate cancer – lessons from the past for success in the future

✍ Karim Fizazi; Heather A. Payne; John Staffurth 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) ⚖ 274 KB

Integrated data from 2 randomized, doubl

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

✍ Celestia S. Higano; Paul F. Schellhammer; Eric J. Small; Patrick A. Burch; John 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

## Abstract ## BACKGROUND: Sipuleucel‐T is an investigational active cellular immunotherapy product designed to stimulate an immune response against prostate cancer. The safety and efficacy of sipuleucel‐T was evaluated in 2 identically designed, randomized, double‐blind, placebo‐controlled trials

356 Oncologic outcomes in patients under

356 Oncologic outcomes in patients undergoing robot-assisted laparoscopic radical prostatectomy for clinical locally advanced T3a prostate cancer

✍ A.P. Labanaris; V. Zugor; C. Wagner; P. Lange; J.H. Witt 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Androgen-Deprivation Therapy in Prostate

Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

✍ Glenn N. Levine; Anthony V. D'Amico; Peter Berger; Peter E. Clark; Robert H. Eck 📂 Article 📅 2010 🏛 American Cancer Society 🌐 English ⚖ 123 KB

Re: Androgen-Deprivation Therapy in Pros

Re: Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

✍ Joseph A. Smith Jr. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Re: Androgen-Deprivation Therapy in Pros

Re: Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

✍ Arthur I. Sagalowsky 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 87 KB